Wockhardt Ltd

Divergence Between
Precepts & Practices
Group 7 & 8

COMPANY BACKGROUND
Pharmaceutical and Bio-Technology
company
Market Cap. =$1.3Billion
Annual Turnover=$12.39 Billion
Employees 7900 people globally
Manufacturing Units are in India, UK ,
Ireland, France and USA

Wockhardts Business
Philosophy
Creating Value by understanding & communicating
with its customers & business partners.

Vision
To be the most admired Indian health care group

Code of business conduct and ethics for directors

and senior managers.

Code dwells on the areas

of
Conflicts of Interests
Misuse of corporate opportunities
Compliance with applicable law
Dealing with accounting complains
Maintaining Confidentiality of informtion

NON COMPLIANCE OF
FDA REGULATIONS
Failed to comply with FDA regulation for
Aurangabad manufacturing unit.

Didnt produce complete and accurate information

about its production batch.

At least dozens of letters from FDA were issued for

non compliance of rules.

UNETHICAL ISSUES RELATING

BREAST-FEEDING
REGULATIONS
Didnt adhere to The infant milk

substitutes and feeding bottles and infant

food Act (1992) by Govt. of India

Distributed free samples which was

against the law

VICTIMIZATION OF
EMPLOYEES
Involved in unethical practices which

includes:1.

Denied the fundamental trade union rights of the union

2.

Restored to hire & fire kind of practice

3.

Increased the work load imposed on workers

Field workers were being treated badly

Provided with low wages

Poor working conditions

UNETHICAL SALES &

MARKETING PRACTICES
Even after getting request letter from FMRAI
(Federation of Medical Representatives Association
of India), company treated field workers very badly.

Discontinued talk with FMRAI

Field workers went on strike against anti-labour

policies

PROMOTING HEALTH CARE SYSTEM

THROUGH IMPROPERLY LABELLED SAMPLES
Infant food samples should conform to labelling
requirements

WOCKHARDT distributes free samples of Dexrice

to doctors

Samples packs of Dexrice, an infant food

do not conform to labelling requirements.

CONCLUSION
Huge difference between precepts and
practices.
The Pharmaceutical Company should follow the rules
regulation made by the govt.
Companyshould follow Biotechnological,
environmental,social ethics.
Malpractices affects the external and
internal environment.
They should be very clear in labelling, employee security,
and social responsibility.

THANK YOU